Open
Notice of Early Expiration of PAR-25-300, "Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)"
National Institutes of Health (NIH)
About this opportunity
National Institute of Allergy and Infectious Diseases (NIAID) The purpose of this Notice is to inform the extramural community that PAR-25-300, “Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)” will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO). National Institute of Allergy and Infectious Diseases
Finding similar opportunities...